Viewing Study NCT02081495


Ignite Creation Date: 2025-12-24 @ 2:08 PM
Ignite Modification Date: 2026-02-12 @ 2:19 PM
Study NCT ID: NCT02081495
Status: COMPLETED
Last Update Posted: 2016-11-11
First Post: 2014-03-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer
Sponsor: Janssen Research & Development, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module